BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Orig3n » Page 2

Top 5 Stem Cell Interviews of 2015

December 27, 2015 By Cade Hildreth (CEO) Leave a Comment

Top 5 Stem Cell Interviews of 2015

As 2016 approaches, it is an important time to look back on 2015 and all that the year entailed for stem cell advances. During 2016, I was honored to have interviewed a number of key thought leaders in the stem cell space, including the CEO of the largest dental stem cell company in the world (Tony Veverka of BioEden), Chief Business Officer for a company creating the world’s largest blood cell repository for iPSC production (James Lovgren of ORIG3N), and VP of Research and Development for one of the most innovative companies operating within the stem cell sector (Dr. Grynspan of Stem Cell Medicine).

Throughout 2015, my team and I conducted dozens of other interviews as well, with stem cell executives, investors, and researchers. These interviews were published on our stem cell industry blog and also  informed market projections for BioInformant’s stem cell and cord blood market intelligence reports. [Read more…]

Filed Under: HSCs, iPS Cells, MSCs, Stem Cells Tagged With: Accellta, Auxocell, BioEden, interview, Orig3n, perinatal stem cells, Q&A

ORIG3N™, Creator of the World’s Largest iPSC Bank, Closes $12.5 Million in Funding from Investor Syndicate

December 17, 2015 By Cade Hildreth (CEO) Leave a Comment

ORIG3N™ Closes $12.5 Million in Funding Lead by Hatteras Venture Partners and Syno Capital - DNA molecule

ORIG3N is an interesting and innovative induced pluripotent stem cell (iPSC) company that describes itself as “leading a transformation in the understanding and treatment of rare, genetically inherited disease.” I am fascinated by the company, because it is one of the only biotechnology companies worldwide to bring their products and services directly to the public.

Specifically, ORIG3N has created the world’s largest uniformly consented blood cell repository, LifeCapsule, and it is using these blood cells to produce patient-specific induced pluripotent stem cells (iPSCs). In addition to collecting donated blood samples for iPSC production, ORIG3N also offers an optional LifeCapsule membership, in which the public can pay $99/year to get permanent access to their own immortalized iPSCs.

You can learn more about the company by reading this fascinating interview with James Lovgren, Chief Business Officer of ORIG3N. It was my honor to meet with him at the recent World Stem Cell Summit in Atlanta, GA. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, James Lovgren, Orig3n, press release, stem cells

ORIG3N, World’s Largest Blood Cell Repository for iPS Cell Production

December 12, 2015 By Cade Hildreth (CEO) Leave a Comment

ORIG3N iPS Cells

ORIG3N LogoORIG3N, an innovative biotech company that creating the world’s largest blood cell repository for induced pluripotent stem cell (iPS cell / iPSC) production. When James Lovgren, Chief Business Officer of ORIG3N, and I met at the World Stem Cell Summit, we intended to explore potential collaborations and synergy between our companies. Instead we had an inspired conversation about the global importance of iPS cells, stem cell market dynamics, and the importance of social platforms to the stem cell community.

I was so inspired by ORIG3N’s vision that I took advantage of the opportunity to interview Mr. Lovgren. [Read more…]

Filed Under: Interviews, iPS Cells, Stem Cells Tagged With: interview, iPSC, James Lovgren, market news, Orig3n, Q&A, stem cells

  • « Previous Page
  • 1
  • 2

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.